Summit Therapeutics (SMMT) Income from Continuing Operations (2017 - 2024)
Summit Therapeutics (SMMT) recorded Income from Continuing Operations of -$65.62 million in Q4 2024, compared with -$36.21 million a year earlier.
Powered by 
Analysis
Summit Therapeutics (SMMT) Income from Continuing Operations (2017 - 2024) Analysis & Trends
For FY2024, Summit Therapeutics reported Income from Continuing Operations of -$234.68 million.
- Across earlier years, Income from Continuing Operations came in at -$614.93 million in FY2023, -$78.78 million in FY2022, -$88.6 million in FY2021 and -$52.7 million in FY2020.
- The Q4 2024 figure is the lowest quarterly Income from Continuing Operations since Q1 2023.
- Per Business Quant, the preceding three quarters came in at -$60.83 million (Q3 2024), -$62.72 million (Q2 2024) and -$45.51 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Summit Therapeutics | 12.28 Bn | 10.04 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -65.62 Mn |
| Sep 30, 2024 | -60.83 Mn |
| Jun 30, 2024 | -62.72 Mn |
| Mar 31, 2024 | -45.51 Mn |
| Dec 31, 2023 | -36.21 Mn |
| Sep 30, 2023 | -20.49 Mn |
| Jun 30, 2023 | -15.79 Mn |
| Mar 31, 2023 | -537.15 Mn |
| Dec 31, 2022 | -20.30 Mn |
| Sep 30, 2022 | -16.94 Mn |
| Jun 30, 2022 | -12.69 Mn |
| Mar 31, 2022 | -22.16 Mn |
| Dec 31, 2021 | -27.10 Mn |
| Sep 30, 2021 | -19.60 Mn |
| Jun 30, 2021 | -24.42 Mn |
| Mar 31, 2021 | -17.49 Mn |
| Dec 31, 2020 | -13.54 Mn |
| Sep 30, 2020 | -17.74 Mn |
| Jun 30, 2020 | -15.28 Mn |
| Mar 31, 2020 | -6.33 Mn |
API Access
Summit Therapeutics Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=SMMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "SMMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=SMMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();